Pharmacodynamics of teicoplanin against MRSA. - Wikidata - wikimedia - TriplyDB

Pharmacodynamics of teicoplanin against MRSA.

Pharmacodynamics of teicoplanin against MRSA.

http://www.wikidata.org/entity/Q41992893

about

Pharmacodynamics of teicoplanin against MRSA.

http://www.wikidata.org/entity/Q41992893

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacodynamics of teicoplanin against MRSA.

@en

type

label

Pharmacodynamics of teicoplanin against MRSA.

@en

prefLabel

Pharmacodynamics of teicoplanin against MRSA.

@en

P1433

Q41992893-57E3396B-54F8-4751-91A2-900ABD165C4C

P1476

Q41992893-7684F983-B412-453E-9994-2AABAE2F8DCA

P2093

Q41992893-1DCE853E-E86E-4A8D-AACA-0413A2A7589F

Q41992893-1E2389A6-37F6-4F13-9490-05B494E920FE

Q41992893-1FB86F80-8B9C-4227-9D8D-C457D6EC2008

Q41992893-25D229CD-3BA0-45AA-8945-DA0495A03999

Q41992893-60C96044-C50D-4C9C-BA63-0DC755DB38D3

Q41992893-8ABD0A3C-42CD-448D-B45D-8182B7E35EA6

Q41992893-ACFCD163-4B77-4343-9169-8963D612F01E

Q41992893-B3B13DD3-0CD3-4435-AE96-EFF6E6B3F97B

P2860

Q41992893-270A468D-261B-4224-A08C-E2972468DE07

Q41992893-352324AE-E0BE-48E9-A405-00F4F2715BCF

Q41992893-45969139-2060-4270-BD29-8306B5C923BF

Q41992893-4F7AFC48-9F4A-4D14-9EA2-A65552949D96

Q41992893-56847DD4-078A-4FA5-B5A0-796EFE7EA4EE

Q41992893-6B65F041-BA94-4058-84ED-F6A0507FB8A5

Q41992893-72390F48-2311-4AF8-A152-73373866F8AE

Q41992893-7321F05D-C744-4D89-858C-E2D4C6A0E039

Q41992893-734AAAD2-A874-4539-A8CC-4FD657804CB5

Q41992893-829FE7B1-F462-404A-BEEE-D7E27C9EBCB6

P31

Q41992893-03130794-1C40-4C6F-BFB6-F8CCA9751ACC

P356

Q41992893-823061DF-705F-44AF-B54E-7D30AAE54DB6

P407

Q41992893-28406B57-D351-4490-9225-69680480FE3A

P50

Q41992893-B6623900-1524-4294-ABC5-29301B1085F6

P577

Q41992893-6DB140C7-D298-4CAB-AFF2-E5802B75CC1E

P698

Q41992893-BB401174-0EC2-4BF7-9F64-DCC44CE7F924

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Pharmacodynamics of teicoplanin against MRSA.

@en

P2093

A Johnson

http://www.w3.org/2001/XMLSchema#string

F Pea

http://www.w3.org/2001/XMLSchema#string

K Padmore

http://www.w3.org/2001/XMLSchema#string

L McEntee

http://www.w3.org/2001/XMLSchema#string

M N Neely

http://www.w3.org/2001/XMLSchema#string

N Farrington

http://www.w3.org/2001/XMLSchema#string

P Cojutti

http://www.w3.org/2001/XMLSchema#string

V Ramos-Martín

http://www.w3.org/2001/XMLSchema#string

P2860

Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model

Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases

In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria.

Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection

Clinical pharmacokinetics of teicoplanin.

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

Pharmacokinetic-pharmacodynamic relationships describing the efficacy of oritavancin in patients with Staphylococcus aureus bacteremia.

Population pharmacokinetics of teicoplanin in children.

Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infection

Clinical pharmacodynamics of quinolones.

P31

scholarly article

P356

10.1093/JAC/DKX289

http://www.w3.org/2001/XMLSchema#string

P407

P50

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28962026

http://www.w3.org/2001/XMLSchema#string